TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy
Abstract Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents, which is characterized by dysfunctional autophagy and poor differentiation. Our recent studies have suggested that the tripartite motif containing-21 (TRIM21) plays a crucial role in regulating OS...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-020-03364-2 |
_version_ | 1818561107432833024 |
---|---|
author | Huan-Tian Zhang Qingzhong Zeng Baomeng Wu Junlei Lu Kui-Leung Tong Jiebin Lin Qiu-Yu Liu Lipei Xu Jie Yang Xiaohui Liu Wanting Liu Yun-Fang Zhang Qionghua Lian Langxia Liu Xuejuan Gao |
author_facet | Huan-Tian Zhang Qingzhong Zeng Baomeng Wu Junlei Lu Kui-Leung Tong Jiebin Lin Qiu-Yu Liu Lipei Xu Jie Yang Xiaohui Liu Wanting Liu Yun-Fang Zhang Qionghua Lian Langxia Liu Xuejuan Gao |
author_sort | Huan-Tian Zhang |
collection | DOAJ |
description | Abstract Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents, which is characterized by dysfunctional autophagy and poor differentiation. Our recent studies have suggested that the tripartite motif containing-21 (TRIM21) plays a crucial role in regulating OS cell senescence and proliferation via interactions with several proteins. Yet, its implication in autophagy and differentiation in OS is largely unknown. In the present study, we first showed that TRIM21 could promote OS cell autophagy, as determined by the accumulation of LC3-II, and the degradation of cargo receptor p62. Further, we were able to identify that Annexin A2 (ANXA2), as a novel interacting partner of TRIM21, was critical for TIRM21-induced OS cell autophagy. Although TRIM21 had a negligible effect on the mRNA and protein expressions of ANXA2, we did find that TRIM21 facilitated the translocation of ANXA2 toward plasma membrane (PM) in OS cells through a manner relying on TRIM21-mediated cell autophagy. This functional link has been confirmed by observing a nice co-expression of TRIM21 and ANXA2 (at the PM) in the OS tissues. Mechanistically, we demonstrated that TRIM21, via facilitating the ANXA2 trafficking at the PM, enabled to release the transcription factor EB (TFEB, a master regulator of autophagy) from the ANXA2-TFEB complex, which in turn entered into the nucleus for the regulation of OS cell autophagy. In accord with previous findings that autophagy plays a critical role in the control of differentiation, we also demonstrated that autophagy inhibited OS cell differentiation, and that the TRIM21/ANXA2/TFEB axis is implicated in OS cell differentiation through the coordination with autophagy. Taken together, our results suggest that the TRIM21/ANXA2/TFEB axis is involved in OS cell autophagy and subsequent differentiation, indicating that targeting this signaling axis might lead to a new clue for OS treatment. |
first_indexed | 2024-12-14T00:46:43Z |
format | Article |
id | doaj.art-a2b7b8d8c4be4c11b762ee1100ed1645 |
institution | Directory Open Access Journal |
issn | 2041-4889 |
language | English |
last_indexed | 2024-12-14T00:46:43Z |
publishDate | 2021-01-01 |
publisher | Nature Publishing Group |
record_format | Article |
series | Cell Death and Disease |
spelling | doaj.art-a2b7b8d8c4be4c11b762ee1100ed16452022-12-21T23:24:06ZengNature Publishing GroupCell Death and Disease2041-48892021-01-0112111410.1038/s41419-020-03364-2TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagyHuan-Tian Zhang0Qingzhong Zeng1Baomeng Wu2Junlei Lu3Kui-Leung Tong4Jiebin Lin5Qiu-Yu Liu6Lipei Xu7Jie Yang8Xiaohui Liu9Wanting Liu10Yun-Fang Zhang11Qionghua Lian12Langxia Liu13Xuejuan Gao14Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, Jinan UniversityKey Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, Jinan UniversityKey Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, Jinan UniversityKey Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, Jinan UniversityDepartment of Bone and Joint Surgery, Institute of Orthopedic Diseases, The First Affiliated Hospital, Jinan UniversityDepartment of Bone and Joint Surgery, Institute of Orthopedic Diseases, The First Affiliated Hospital, Jinan UniversityDepartment of Pathology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou UniversityKey Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, Jinan UniversityDepartment of Bone and Joint Surgery, Institute of Orthopedic Diseases, The First Affiliated Hospital, Jinan UniversityKey Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, Jinan UniversityKey Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, Jinan UniversityCenter of Kidney Disease, Huadu District People’s Hospital, Southern Medical UniversityKey Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, Jinan UniversityKey Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, Jinan UniversityKey Laboratory of Functional Protein Research of Guangdong Higher Education Institutes and MOE Key Laboratory of Tumor Molecular Biology, Institute of Life and Health Engineering, Jinan UniversityAbstract Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents, which is characterized by dysfunctional autophagy and poor differentiation. Our recent studies have suggested that the tripartite motif containing-21 (TRIM21) plays a crucial role in regulating OS cell senescence and proliferation via interactions with several proteins. Yet, its implication in autophagy and differentiation in OS is largely unknown. In the present study, we first showed that TRIM21 could promote OS cell autophagy, as determined by the accumulation of LC3-II, and the degradation of cargo receptor p62. Further, we were able to identify that Annexin A2 (ANXA2), as a novel interacting partner of TRIM21, was critical for TIRM21-induced OS cell autophagy. Although TRIM21 had a negligible effect on the mRNA and protein expressions of ANXA2, we did find that TRIM21 facilitated the translocation of ANXA2 toward plasma membrane (PM) in OS cells through a manner relying on TRIM21-mediated cell autophagy. This functional link has been confirmed by observing a nice co-expression of TRIM21 and ANXA2 (at the PM) in the OS tissues. Mechanistically, we demonstrated that TRIM21, via facilitating the ANXA2 trafficking at the PM, enabled to release the transcription factor EB (TFEB, a master regulator of autophagy) from the ANXA2-TFEB complex, which in turn entered into the nucleus for the regulation of OS cell autophagy. In accord with previous findings that autophagy plays a critical role in the control of differentiation, we also demonstrated that autophagy inhibited OS cell differentiation, and that the TRIM21/ANXA2/TFEB axis is implicated in OS cell differentiation through the coordination with autophagy. Taken together, our results suggest that the TRIM21/ANXA2/TFEB axis is involved in OS cell autophagy and subsequent differentiation, indicating that targeting this signaling axis might lead to a new clue for OS treatment.https://doi.org/10.1038/s41419-020-03364-2 |
spellingShingle | Huan-Tian Zhang Qingzhong Zeng Baomeng Wu Junlei Lu Kui-Leung Tong Jiebin Lin Qiu-Yu Liu Lipei Xu Jie Yang Xiaohui Liu Wanting Liu Yun-Fang Zhang Qionghua Lian Langxia Liu Xuejuan Gao TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy Cell Death and Disease |
title | TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy |
title_full | TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy |
title_fullStr | TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy |
title_full_unstemmed | TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy |
title_short | TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy |
title_sort | trim21 regulated annexin a2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the tfeb mediated autophagy |
url | https://doi.org/10.1038/s41419-020-03364-2 |
work_keys_str_mv | AT huantianzhang trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT qingzhongzeng trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT baomengwu trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT junleilu trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT kuileungtong trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT jiebinlin trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT qiuyuliu trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT lipeixu trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT jieyang trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT xiaohuiliu trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT wantingliu trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT yunfangzhang trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT qionghualian trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT langxialiu trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy AT xuejuangao trim21regulatedannexina2plasmamembranetraffickingfacilitatesosteosarcomacelldifferentiationthroughthetfebmediatedautophagy |